Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New company in stealth mode
Cambridge, England, United Kingdomnew-company-in-stealth-mode.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Syndex Bio is a newly established biotechnology company operating in stealth mode, meaning it has not publicly disclosed detailed information about its technology, pipeline, or clinical results. The company is based in Cambridge, UK and was founded in 2022. As of now, there are no public reports of clinical results or programs.
- Industry
- Biotech
Beyond the preview
Go deeper on New company in stealth mode.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New company in stealth mode.